» Articles » PMID: 33364589

Selection-driven Tumor Evolution with Public Goods Leads to Patterns of Clonal Expansion Consistent with Neutral Growth

Overview
Journal iScience
Publisher Cell Press
Date 2020 Dec 28
PMID 33364589
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers are the result of eco-evolutionary processes fueled by heritable phenotypic diversification and driven by environmentally dependent selection. Space represents a key growth-limiting ecological resource, the ability to explore this resource is likely under strong selection. Using agent-based modeling, we explored the interplay between phenotypic strategies centered on gaining access to new space through cell-extrinsic degradation of extracellular matrix barriers and the exploitation of this resource through maximizing cell proliferation. While cell proliferation is a cell-intrinsic property, newly accessed space represents a public good, which can benefit both producers and non-producers. We found that this interplay results in ecological succession, enabling emergence of large, heterogeneous, and highly proliferative populations. Even though in our simulations both remodeling and proliferation strategies were under strong positive selection, their interplay led to sub-clonal architecture that could be interpreted as evidence for neutral evolution, warranting cautious interpretation of inferences from sequencing of cancer genomes.

Citing Articles

A modelling framework for cancer ecology and evolution.

Adler F J R Soc Interface. 2024; 21(216):20240099.

PMID: 39013418 PMC: 11251767. DOI: 10.1098/rsif.2024.0099.


"Patchiness" in mechanical stiffness across a tumor as an early-stage marker for malignancy.

Mirzakhel Z, Reddy G, Boman J, Manns B, Veer S, Katira P BMC Ecol Evol. 2024; 24(1):33.

PMID: 38486161 PMC: 10938681. DOI: 10.1186/s12862-024-02221-6.


Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.

Neagu A, Whitham D, Bruno P, Arshad A, Seymour L, Morrissiey H Int J Mol Sci. 2024; 25(3).

PMID: 38338903 PMC: 10855488. DOI: 10.3390/ijms25031628.


Metabolic activity grows in human cancers pushed by phenotypic variability.

Bosque J, Calvo G, Molina-Garcia D, Perez-Beteta J, Garcia Vicente A, Perez-Garcia V iScience. 2023; 26(3):106118.

PMID: 36843844 PMC: 9950952. DOI: 10.1016/j.isci.2023.106118.


Agent-based methods facilitate integrative science in cancer.

West J, Robertson-Tessi M, Anderson A Trends Cell Biol. 2022; 33(4):300-311.

PMID: 36404257 PMC: 10918696. DOI: 10.1016/j.tcb.2022.10.006.


References
1.
Marusyk A, Tabassum D, Altrock P, Almendro V, Michor F, Polyak K . Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature. 2014; 514(7520):54-8. PMC: 4184961. DOI: 10.1038/nature13556. View

2.
Basanta D, Anderson A . Exploiting ecological principles to better understand cancer progression and treatment. Interface Focus. 2014; 3(4):20130020. PMC: 3915838. DOI: 10.1098/rsfs.2013.0020. View

3.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

4.
Swanton C . Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012; 72(19):4875-82. PMC: 3712191. DOI: 10.1158/0008-5472.CAN-12-2217. View

5.
Williams M, Werner B, Heide T, Curtis C, Barnes C, Sottoriva A . Quantification of subclonal selection in cancer from bulk sequencing data. Nat Genet. 2018; 50(6):895-903. PMC: 6475346. DOI: 10.1038/s41588-018-0128-6. View